Notwithstanding the ongoing coronavirus disease-2019 (Covid-19) pandemic, information
on its clinical presentation and prognosis in recipients of a kidney transplant remain scanty. …

There are no studies which have compared the risk of severe COVID‐19 and related mortality
between transplant recipients and nontransplant patients. We enrolled two groups of …

Background COVID-19 has been associated with high morbidity and mortality in kidney
transplant recipients. However, risk factors for COVID-19 disease in patients with kidney …

End stage kidney disease increase the risk of COVID-19 related death but how the kidney
replacement strategy should be adapted during the pandemic is unknown. Chronic …

A 79-year-old male of African ancestry, with a history of hemorrhagic stroke, monoclonal
gammopathy of unknown significance and chronic kidney disease stage 3 due to hypertension …

Discussion In this study comprising 494 KTRs, we found that elevations of markers of
inflammation, cardiac injury, and thrombosis were significantly associated with an increased …

Rituximab (RTX) therapy for primary focal segmental glomerulosclerosis recurrence after
kidney transplantation (KT) has been extensively debated. We aimed to assess the benefit of …

Background The access of obese patients to kidney transplantation is limited despite several
studies showing that obese transplant recipients had a better survival rate than those …

Introduction SARS-CoV-2 pandemic evolved in 2 consecutive waves during 2020.
Improvements in the management of COVID-19 led to a reduction in mortality rates among …

The impact of immunosuppressive therapy (IS) strategies after kidney transplant failure (KTF)
on potential future new grafts is poorly established. We assessed the potential benefit of …